Hattaya Benya-aphikul

Dr. Hattaya Benya-aphikul

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
WBWeerawan Boonlert
Weerawan Boonlert
HBHattaya Benya-aphikul
Hattaya Benya-aphikul
Jariya Umka WelbatJariya Umka Welbat
Jariya Umka Welbat
RRRatchanee Rodsiri
Ratchanee Rodsiri
The decrease of brain-derived neurotrophic factor (BDNF) has been reported in alcohol use disorder and major depression. The effective treatment of these comorbid diseases remains undiscovered. Nutraceutical products are therefore proposed as an alternative approach to overcome this challenge. Ginseng extract G115, the standardized extract of Panax ginseng, is a widely-used nutraceutical that is beneficial for various central nervous system disorders. This study aimed to determine the antidepressant effect of ginseng extract G115 in ethanol-treated mice models. Mice received either water, amitriptyline, or various doses of G115 (p.o.) followed by water or ethanol (i.p.) for 8 days. The antidepressant activity was evaluated using forced swimming test. BDNF levels were measured from hippocampal and prefrontal cortex tissues. The results demonstrated that the increase of immobility time in depressant mice induced by ethanol was reversed by both G115 and amitriptyline treatment. A significant increase of BDNF levels in the hippocampus and prefrontal cortex was observed in ethanol-treated mice receiving G115. Taken together, this study provides scientific information on the use of G115 as an antidepressant that could be further used as a dietary supplement in comorbid alcohol use and major depressive disorders.

1 October 2021 in Toxicology Letters
Verified
Journal Article
Closed access
HBHattaya Benya-aphikul
Hattaya Benya-aphikul
VPVarisa Pongrakhananon
Varisa Pongrakhananon
PCPaninee Chetprayoon
Paninee Chetprayoon
TSThongchai Sooksawate
Thongchai Sooksawate
RRRatchanee Rodsiri
Ratchanee Rodsiri

1 January 2024 in Advances in Pharmacological and Pharmaceutical Sciences
Verified
Journal Article
Open access
SMSu Lwin Lwin Myint
Su Lwin Lwin Myint
RRRatchanee Rodsiri
Ratchanee Rodsiri
HBHattaya Benya-aphikul
Hattaya Benya-aphikul
TRTissana Rojanaratha
Tissana Rojanaratha
GRGarnpimol C. Ritthidej
Garnpimol C. Ritthidej
RIRidho Islamie
Ridho Islamie
Asiatic acid (AA) has previously shown its neuroprotective effects, but low oral bioavailability limits its penetration into the brain. This study aimed to investigate the effect of intranasal AA administration in mice with memory dysfunction induced by scopolamine. Mice received either intranasal AA (INAA), oral AA (POAA3 or POAA30), or donepezil, followed by scopolamine for 10 days. Morris water maze (MWM) was performed on days 0–5, 30 min after treatment. Locomotor activity was conducted on day 6 followed by brain collection. In MWM, INAA treatment had significantly reduced escape latency on days 2–4, while POAA3 decreased escape latency on day 3 and POAA30 and donepezil decreased escape latency on day 4. INAA inhibited acetylcholinesterase activity, increased catalase protein expression, and decreased malondialdehyde levels in the brain tissue. Therefore, intranasal administration of AA produced a rapid onset in the protection of learning and memory deficits induced by scopolamine through acetylcholinesterase inhibition and antioxidant effect.